Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Ajooni Biotech Limited ( (IN:AJOONI) ).
Ajooni Biotech Limited has submitted to the National Stock Exchange a confirmation certificate from its registrar and transfer agent, Cameo Corporate Services Limited, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31 December 2025. The certificate confirms that all securities lodged for dematerialisation during the quarter were duly processed, listed in line with existing securities, and that physical certificates were cancelled and replaced with depository records within the stipulated timelines, underscoring the company’s adherence to regulatory norms and reinforcing safeguards for shareholders in terms of proper handling of its dematerialised shares.
More about Ajooni Biotech Limited
Ajooni Biotech Limited is an India-based company in the biotech and related sectors, listed on the National Stock Exchange under the symbol AJOONI. The company operates from Mohali, Punjab, with manufacturing works located on G.T. Road in Khanna, Punjab, and is subject to Indian securities market regulations as a publicly traded entity.
Average Trading Volume: 341,892
Technical Sentiment Signal: Sell
For an in-depth examination of AJOONI stock, go to TipRanks’ Overview page.